Kenya's Lempus banned for five years for doping
Kenya's Betty Lempus has been banned for five years for using
the banned substance triamcinolone acetonide, the Athletics Integrity Unit
(AIU) said on Thursday.
The 31-year-old was tested following her win at the Harmonie
Mutuelle Semi de Paris (Paris Half Marathon) in September 2021.
The AIU said as a consequence it had also disqualified Lempus'
results from the day the test was conducted, meaning she has been stripped of
her Paris title.
"The Athlete has accepted the above Consequences for her
anti-doping rule violations and has expressly waived her right to have those
Consequences determined by the Disciplinary Tribunal at a hearing," the
AIU said in a statement.
Triamcinolone acetonide, a substance prohibited
in-competition when administered in certain ways, falls under the banned
category of glucocorticoids, commonly used as therapeutic substances in sports.
"(Glucocorticoids) are prohibited in-competition
because, when administered via prohibited routes, there is clear evidence of
systemic effects which could potentially enhance performance and be harmful to
health," the AIU said.
Their use is permitted if athletes can produce an exemption
or proof that administration is not through a prohibited route.
Lembus had claimed the substance had entered her system through
a medical injection in August 2021 by Dr Philip Murey at the Uasin Gishu
County Hospital in Eldoret.
An investigation by the AIU, with the help of the Anti-Doping
Agency of Kenya (“ADAK”), revealed she did not receive the injection and the hospital
did not employ a Dr Philip Murey.
Want to send us a story? Submit on Wananchi Reporting on the Citizen Digital App or Send an email to wananchi@royalmedia.co.ke or Send an SMS to 25170 or WhatsApp on 0743570000
Comments
No comments yet.
Leave a Comment